These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12860725)

  • 1. Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis.
    Haringman JJ; Kraan MC; Smeets TJ; Zwinderman KH; Tak PP
    Ann Rheum Dis; 2003 Aug; 62(8):715-21. PubMed ID: 12860725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment for rheumatoid arthritis by chemokine blockade].
    Nanki T
    Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(3):172-80. PubMed ID: 27320932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis.
    Haringman JJ; Smeets TJ; Reinders-Blankert P; Tak PP
    Ann Rheum Dis; 2006 Mar; 65(3):294-300. PubMed ID: 16107514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the monoclonal antibody ASK8007 blocking osteopontin in patients with rheumatoid arthritis: a randomised, placebo controlled, proof-of-concept study.
    Boumans MJ; Houbiers JG; Verschueren P; Ishikura H; Westhovens R; Brouwer E; Rojkovich B; Kelly S; den Adel M; Isaacs J; Jacobs H; Gomez-Reino J; Holtkamp GM; Hastings A; Gerlag DM; Tak PP
    Ann Rheum Dis; 2012 Feb; 71(2):180-5. PubMed ID: 21917822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis.
    Katschke KJ; Rottman JB; Ruth JH; Qin S; Wu L; LaRosa G; Ponath P; Park CC; Pope RM; Koch AE
    Arthritis Rheum; 2001 May; 44(5):1022-32. PubMed ID: 11352233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synovial Immunophenotype and Anti-Citrullinated Peptide Antibodies in Rheumatoid Arthritis Patients: Relationship to Treatment Response and Radiologic Prognosis.
    Orr C; Najm A; Biniecka M; McGarry T; Ng CT; Young F; Fearon U; Veale DJ
    Arthritis Rheumatol; 2017 Nov; 69(11):2114-2123. PubMed ID: 28732135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection, identification and in vivo treatment responsiveness of bone morphogenetic protein (BMP)-activated cell populations in the synovium of patients with rheumatoid arthritis.
    Verschueren PC; Lories RJ; Daans M; Théate I; Durez P; Westhovens R; Luyten FP
    Ann Rheum Dis; 2009 Jan; 68(1):117-23. PubMed ID: 18276742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage subpopulations in rheumatoid synovium: reduced CD163 expression in CD4+ T lymphocyte-rich microenvironments.
    Fonseca JE; Edwards JC; Blades S; Goulding NJ
    Arthritis Rheum; 2002 May; 46(5):1210-6. PubMed ID: 12115225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MLN3897 plus methotrexate in patients with rheumatoid arthritis: safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study.
    Vergunst CE; Gerlag DM; von Moltke L; Karol M; Wyant T; Chi X; Matzkin E; Leach T; Tak PP
    Arthritis Rheum; 2009 Dec; 60(12):3572-81. PubMed ID: 19950299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial.
    Vergunst CE; Gerlag DM; Lopatinskaya L; Klareskog L; Smith MD; van den Bosch F; Dinant HJ; Lee Y; Wyant T; Jacobson EW; Baeten D; Tak PP
    Arthritis Rheum; 2008 Jul; 58(7):1931-9. PubMed ID: 18576354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toreforant, an orally active histamine H
    Boyle DL; DePrimo SE; Calderon C; Chen D; Dunford PJ; Barchuk W; Firestein GS; Thurmond RL
    Inflamm Res; 2019 Apr; 68(4):261-274. PubMed ID: 30739130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis.
    Haringman JJ; Gerlag DM; Zwinderman AH; Smeets TJ; Kraan MC; Baeten D; McInnes IB; Bresnihan B; Tak PP
    Ann Rheum Dis; 2005 Jun; 64(6):834-8. PubMed ID: 15576415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the dendritic cell-associated C-type lectin DC-SIGN by inflammatory matrix metalloproteinase-producing macrophages in rheumatoid arthritis synovium and interaction with intercellular adhesion molecule 3-positive T cells.
    van Lent PL; Figdor CG; Barrera P; van Ginkel K; Slöetjes A; van den Berg WB; Torensma R
    Arthritis Rheum; 2003 Feb; 48(2):360-9. PubMed ID: 12571844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection.
    Yun JJ; Whiting D; Fischbein MP; Banerji A; Irie Y; Stein D; Fishbein MC; Proudfoot AE; Laks H; Berliner JA; Ardehali A
    Circulation; 2004 Feb; 109(7):932-7. PubMed ID: 14757698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokine and chemokine receptor blockade in arthritis, a prototype of immune-mediated inflammatory diseases.
    Szekanecz Z; Koch AE; Tak PP
    Neth J Med; 2011 Sep; 69(9):356-66. PubMed ID: 21978977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatoid fibroblast-like synoviocytes overexpress the chemokine stromal cell-derived factor 1 (CXCL12), which supports distinct patterns and rates of CD4+ and CD8+ T cell migration within synovial tissue.
    Bradfield PF; Amft N; Vernon-Wilson E; Exley AE; Parsonage G; Rainger GE; Nash GB; Thomas AM; Simmons DL; Salmon M; Buckley CD
    Arthritis Rheum; 2003 Sep; 48(9):2472-82. PubMed ID: 13130466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trial.
    Tak PP; Balanescu A; Tseluyko V; Bojin S; Drescher E; Dairaghi D; Miao S; Marchesin V; Jaen J; Schall TJ; Bekker P
    Ann Rheum Dis; 2013 Mar; 72(3):337-44. PubMed ID: 22589376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of methotrexate on the increased CCR2 density on circulating CD4 T lymphocytes and monocytes in active chronic rheumatoid arthritis, with a down regulation only on monocytes in responders.
    Ellingsen T; Hornung N; Møller BK; Poulsen JH; Stengaard-Pedersen K
    Ann Rheum Dis; 2007 Feb; 66(2):151-7. PubMed ID: 16905577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR5 blockade in rheumatoid arthritis: a randomised, double-blind, placebo-controlled clinical trial.
    van Kuijk AW; Vergunst CE; Gerlag DM; Bresnihan B; Gomez-Reino JJ; Rouzier R; Verschueren PC; van der Leij C; Maas M; Kraan MC; Tak PP
    Ann Rheum Dis; 2010 Nov; 69(11):2013-6. PubMed ID: 20693270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis.
    Taylor PC; Peters AM; Paleolog E; Chapman PT; Elliott MJ; McCloskey R; Feldmann M; Maini RN
    Arthritis Rheum; 2000 Jan; 43(1):38-47. PubMed ID: 10643698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.